Literature DB >> 12104063

The influence of diabetes mellitus on late clinical outcomes following coronary stent implantation.

Hirotoshi Kamishirado1, Teruo Inoue, Masashi Sakuma, Toshihiko Uchida, Saeko Tsuda, Kan Takayanagi, Terumi Hayashi, Shigenori Morooka.   

Abstract

Diabetic patients have a higher restenosis rate and late morbidity following balloon angioplasty. However, the increased risk of restenosis after coronary stent implantation in diabetic patients is controversial. We compared the quantitative coronary angiographic (QCA) variables between 42 diabetic patients and 71 non-diabetic patients undergoing coronary stent implantation and for 6 months follow-up. Pre-procedural variables were identical in the diabetic and non-diabetic patients. The stent-artery ratio was lower (1.07+/-0.13 vs. 1.13+/-0.13, P=0.020), and acute gain after coronary stenting was lower (1.58+/-0.53 vs. 1.77+/-0.48, P=0.049) in the diabetic patients than in the non-diabetic patients. However, the late lumen loss (0.42+/-0.64 vs. 0.49+/-0.69), loss index (0.28+/-0.49 vs. 0.28+/-0.45), restenosis rate (19 vs. 23%) and target lesion revascularization rate (17 vs. 18%) after 6 months were identical in the diabetic and non-diabetic patients. These results suggest that diabetes itself does not increase stent restenosis.

Entities:  

Mesh:

Year:  2002        PMID: 12104063     DOI: 10.1016/s0167-5273(02)00079-7

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  1 in total

1.  Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents.

Authors:  Michael T Halpern; Michael Lacey; Mary Ann Clark; Miguel A Valentin
Journal:  BMC Cardiovasc Disord       Date:  2004-12-13       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.